Patient Comfort Using Green vs. Yellow Pan Retinal Photocoagulation

Completed · Not applicable

Conditions studied: Proliferative Diabetic Retinopathy - High Risk

In brief

Our aim is to compare patient comfort when using the 532 nanometer (green) wavelength laser to the 577 nanometer (yellow) wavelength laser during pan retinal photocoagulation to treat patients with diabetic retinopathy. Secondary outcome measures will be power (mW) required to achieve gray-white retinal burns and duration of treatment.

Key facts

Study ID

NCT02995629

Run by

Wills Eye

People needed

40

Starts

2016-03-01

Expected to finish

2016-10-01

Last updated by the study team

2016-12-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patient of Wills Eye Hospital Retina Service and/or Mid Atlantic Retina
• volunteer patients age 18 years and older.
• healthy enough to participate in the study.
• willing and able to consent to participation in the study.
• diagnosis of PDR with HRC based on clinical criteria outlined by the DRS.

You may not qualify if…

• patient less than 18 years of age
• institutionalized patient
• prisoner
• significant media opacity obscuring a view of the superior retina
• history of intra-ocular surgery except cataract surgery
• history of PRP laser within the last 30 days

Where it is running

• Mid Atlantic Retina- Wills Eye Institute — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.